Form 8-K - Current report:
SEC Accession No. 0001640334-25-001240
Filing Date
2025-07-18
Accepted
2025-07-18 16:35:54
Documents
18
Period of Report
2025-07-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K artl_8k.htm   iXBRL 8-K 30169
2 AT THE MARKET OFFERING AGREEMENT artl_ex11.htm EX-1.1 215386
3 OPINION artl_ex51.htm EX-5.1 18696
9 artl_ex51img2.jpg GRAPHIC 3958
10 artl_ex51img1.jpg GRAPHIC 3958
  Complete submission text file 0001640334-25-001240.txt   456867

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA artl-20250718.xsd EX-101.SCH 5024
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE artl-20250718_lab.xml EX-101.LAB 15188
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE artl-20250718_cal.xml EX-101.CAL 898
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE artl-20250718_pre.xml EX-101.PRE 9628
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE artl-20250718_def.xml EX-101.DEF 2099
20 EXTRACTED XBRL INSTANCE DOCUMENT artl_8k_htm.xml XML 4020
Mailing Address 505 LOMAS SANTA FE, SUITE 160 SOLANA BEACH CA 92075
Business Address 505 LOMAS SANTA FE, SUITE 160 SOLANA BEACH CA 92075 858-925-7049
ARTELO BIOSCIENCES, INC. (Filer) CIK: 0001621221 (see all company filings)

EIN.: 331220924 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38951 | Film No.: 251134906
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)